文献类型：期刊文献

英文题名：Analysis of the Current Status and Characteristics of Health Economics Reporting in Clinical Practice Guidelines for 2021-2023

作者：Xing, Xin[1,2,3,4];Zhang, Guohua[5];Kong, Weize[1,2,3];Guo, Liping[1,2,3];Li, Xiuxia[1,2,3,6,7];Wei, Zhipeng[1,2,3];Lu, Yongbin[1,2,3,6,7];White, Howard[1,2];Chen, Yaolong[1,2,3,6,7];Yang, Kehu[1,2,3,6,7]

第一作者：Xing, Xin;邢新

通信作者：Chen, YL[1];Yang, KH[1];Chen, YL[2];Yang, KH[2];Chen, YL[3];Yang, KH[3];Chen, YL[4];Yang, KH[4];Chen, YL[5];Yang, KH[5]

机构：[1]Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou, Gansu, Peoples R China;[2]Lanzhou Univ, Ctr Evidence Based Social Sci, Lanzhou, Gansu, Peoples R China;[3]WHO Collaborating Ctr Guideline Implementat & Know, Lanzhou, Gansu, Peoples R China;[4]Gansu Univ Tradit Chinese Med, Sch Publ Hlth, Dept Epidemiol & Evidence Based Med, Lanzhou, Gansu, Peoples R China;[5]Gansu Univ Tradit Chinese Med, Sch Clin Med 1, Dept Comparat Med, Lanzhou, Gansu, Peoples R China;[6]Key Lab Evidence Based Med Gansu Prov, Lanzhou, Gansu, Peoples R China;[7]Gansu Prov Ctr Med Guideline Ind Technol, Lanzhou, Gansu, Peoples R China

第一机构：Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou, Gansu, Peoples R China

通信机构：[1]corresponding author), Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou, Gansu, Peoples R China;[2]corresponding author), Lanzhou Univ, Ctr Evidence Based Social Sci, Lanzhou, Gansu, Peoples R China;[3]corresponding author), WHO Collaborating Ctr Guideline Implementat & Know, Lanzhou, Gansu, Peoples R China;[4]corresponding author), Key Lab Evidence Based Med Gansu Prov, Lanzhou, Gansu, Peoples R China;[5]corresponding author), Gansu Prov Ctr Med Guideline Ind Technol, Lanzhou, Gansu, Peoples R China.

年份：2025

外文期刊名：JOURNAL OF EVIDENCE BASED MEDICINE

收录：;Scopus(收录号：2-s2.0-105013667203);WOS:【SCI-EXPANDED(收录号:WOS:001560194500001)】；

基金：This study was supported by the National Social Science Fund of China, Major Project "Theoretical System, International Experience, and Pathways of Evidence-Based Social Science in China" (Project No. 19ZDA142), the Medical and Health Technology Innovation Engineering of the Chinese Academy of Medical Sciences, and the Evidence Evaluation and Guidelines Innovation Unit of the Chinese Academy of Medical Sciences (Project No. 2021RU017).r No Statement Available

语种：英文

外文关键词：clinical practice guidelines; expert consensus statements; evidence-based medicine; health economics; reporting quality

摘要：Objective While prior investigations into the reporting of health economics (HE) have predominantly focused on guideline analyses at singular institutional or national levels, this study extends its scope to encompass diverse guidance documents issued transnationally across multiple institutions. Specifically, we evaluated the reporting of HE evidence in international clinical practice guidelines (CPGs) and expert consensus statements published between 2021 and 2023. The findings aim to inform the future revisions and development of such documents.Methods A systematic PubMed search identified relevant CPGs and expert consensus statements within a specified period. Two independent researchers screened the literature, extracted economic evidence integrated into these documents, and employed descriptive analysis to summarize the reporting characteristics.Results Of the 8931 screened publications, 3119 (34.9%) reported HE evidence. Among these 3119 publications, 237 (7.6%) incorporated HE evidence in formulating recommendations, 220 (7.1%) utilized HE evidence for evidence grading, and 2581 (82.8%) referenced HE evidence in explanatory notes accompanying the recommendations.Conclusions Current CPGs and expert consensus statements exhibit low rates of HE evidence reporting, indicating that most international guideline developers have overlooked their applications. HE evidence-through cost-effectiveness and cost-utility analyses-can optimize medical resource allocation, support clinicians in patient-centered economic decision-making, and enhance health outcomes. Future guideline development should prioritize HE evidence integration to advance the scientific rigor and clinical applicability of the recommendations.